Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/137101
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSánchez-López, E. (Elena)-
dc.contributor.authorGuerra, Mariana-
dc.contributor.authorDias-Ferreira, João-
dc.contributor.authorLópez-Machado, Ana-
dc.contributor.authorEttcheto, Miren-
dc.contributor.authorCano, Amanda-
dc.contributor.authorEspina García, Marta-
dc.contributor.authorCamins Espuny, Antoni-
dc.contributor.authorGarcía, Maria Luisa-
dc.contributor.authorSouto, Eliana B.-
dc.date.accessioned2019-07-12T11:36:59Z-
dc.date.available2019-07-12T11:36:59Z-
dc.date.issued2019-05-31-
dc.identifier.issn2079-4991-
dc.identifier.urihttp://hdl.handle.net/2445/137101-
dc.description.abstractNanoemulsions are pharmaceutical formulations composed of particles within a nanometer range. They possess the capacity to encapsulate drugs that are poorly water soluble due to their hydrophobic core nature. Additionally, they are also composed of safe gradient excipients, which makes them a stable and safe option to deliver drugs. Cancer therapy has been an issue for several decades. Drugs developed to treat this disease are not always successful or end up failing, mainly due to low solubility, multidrug resistance (MDR), and unspecific toxicity. Nanoemulsions might be the solution to achieve e cient and safe tumor treatment. These formulations not only solve water-solubility problems but also provide specific targeting to cancer cells and might even be designed to overcome MDR. Nanoemulsions can be modified using ligands of di erent natures to target components present in tumor cells surface or to escape MDR mechanisms. Multifunctional nanoemulsions are being studied by a wide variety of researchers in di erent research areas mainly for the treatment of di erent types of cancer. All of these studies demonstrate that nanoemulsions are e ciently taken by the tumoral cells, reduce tumor growth, eliminate toxicity to healthy cells, and decrease migration of cancer cells to other organs.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3390/nano9060821-
dc.relation.ispartofNanomaterials, 2019, vol. 9, p. 821-
dc.relation.urihttps://doi.org/10.3390/nano9060821-
dc.rightscc-by (c) Sánchez-López, E. (Elena) et al., 2019-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es-
dc.subject.classificationNanopartícules-
dc.subject.classificationCàncer-
dc.subject.classificationSistemes d'alliberament de medicaments-
dc.subject.classificationFarmacologia experimental-
dc.subject.otherNanoparticles-
dc.subject.otherCancer-
dc.subject.otherDrug delivery systems-
dc.subject.otherExperimental pharmacology-
dc.titleCurrent applications of nanoemulsions in cancer therapeutics.-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec690419-
dc.date.updated2019-07-12T11:36:59Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)
Articles publicats en revistes (Farmàcia, Tecnologia Farmacèutica i Fisicoquímica)

Files in This Item:
File Description SizeFormat 
690419.pdf1.42 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons